CORD Corporate Members 2024
- Acadia Pharmaceuticals Inc.
- Alexion/ AstraZeneca Rare Disease
- Alnylam
- BioCryst
- BeiGene
- Biogen
- Boehringer Ingelheim
- Certara
- CSL Behring
- Hoffmann-La Roche
- Incyte Biosciences Canada
- Innomar Strategies
- Ipsen
- Janssen
- Jazz Pharmaceuticals
- McKesson Specialty Health
- Medunik Canada
- Novartis
- Novocure
- Pfizer Canada
- PTC Therapeutics
- Quality & Compliance Services Inc
- Recordati Rare Diseases
- Roche
- Rhythm Pharmaceuticals
-
- Sanofi – Genzyme
- Sentrex Health Solutions
- Servier
- Sobi
- Takeda Canada Inc.
- Ultragenyx Pharmaceutical Inc.
- Vertex Pharmaceuticals